Home LiteratureArticle Details
PMID: 326670 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Protective role of complement in experimental Escherichia coli endocarditis.

Infection and immunity ·Vol. 16 ·No. 1 ·1977-04-00 ·Pages 213-7

Durack DT, Beeson PB

Abstract

Fourteen strains of Escherichia coli were tested for ability to cause infective endocarditis in rabbits prepared by prior placement of an intracardiac catheter. Strains that were resistant to the bactericidal action of serum caused E. coli endocarditis in 91.4% of rabbits, whereas serum-sensitive strains usually failed to cause persisting infection (11.3% infected, P less than 0.001). Although serum-sensitive E. coli lodged on heart valves within 1 h after intravenous injection, they survived less than 24 h in most normal rabbits. In contrast to normals, all five C6-deficient rabbits injected with a serum-sensitive strain of E. coli developed infective endocarditis (P less than 0.005). No correlation was found between the presence of K1 antigen and the incidence of experimental E. coli endocarditis. Thus, the ability of strains of E. coli to establish persisting endocardial infection in rabbits appears to be directly associated with resistance to the complement-mediated serum bactericidal system. These findings may explain in part the rarity of gram-negative bacillary endocarditis in patients; they also indicate that in certain special circumstances the serum bactericidal system can play a decisive role in host defense.

MeSH Terms
Animals Complement C6/deficiency Complement System Proteins Endocarditis, Bacterial/immunology Escherichia coli Infections/immunology Heart/microbiology Rabbits Time Factors
Chemicals
Complement C6 Complement System Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Durack D T
Beeson P B
References (25)
25 references, click to expand
  1. A STUDY OF THE RELATIONSHIP OF THE NORMAL BACTERICIDAL ACTIVITY OF HUMAN SERUM TO BACTERIAL INFECTION.
    J Clin Invest. 1960 Jan;39(1):72-81 PMID: 16695824
  2. IMMUNE BACTERICIDAL ACTIVITY OF COMPLEMENT. SEPARATION AND DESCRIPTION OF INTERMEDIATE STEPS.
    J Immunol. 1964 Aug;93:319-30 PMID: 14202263
  3. The survival of strains of enteric bacilli in the blood stream as related to their sensitivity to the bactericidal effect of serum.
    J Clin Invest. 1960 Jan;39:82-8 PMID: 14437724
  4. Lack of bactericidal effect of mouse serum on a number of common microorganisms.
    Science. 1954 Jun 18;119(3103):877 PMID: 13168383
  5. The changing character of infective endocarditis.
    Am Fam Physician. 1975 Mar;11(3):117-24 PMID: 803764
  6. Infective endocarditis--1973.
    Prog Cardiovasc Dis. 1973 Nov-Dec;16(3):239-74 PMID: 4593514
  7. Homozygous deficiency of C3 in a patient with repeated infections.
    Lancet. 1972 Dec 2;2(7788):1179-81 PMID: 4117597
  8. The complement system of man. I.
    N Engl J Med. 1972 Sep 7;287(10):489-95 PMID: 4114930
  9. The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors.
    J Exp Med. 1969 Jun 1;129(6):1275-90 PMID: 4181833
  10. Complement-dependent biological functions in complement deficiency in man.
    Lancet. 1966 Aug 13;2(7459):356-60 PMID: 4161719
  11. Bactericidal and opsonic properties of C4-deficient guinea pig serum.
    J Immunol. 1972 Sep;109(3):477-86 PMID: 4403402
  12. Serratia marcescens endocarditis: a regional illness associated with intravenous drug abuse.
    Ann Intern Med. 1976 Jan;84(1):29-35 PMID: 1106290
  13. Epidemiology of Escherichia coli K1 in healthy and diseased newborns.
    Lancet. 1975 May 17;1(7916):1099-104 PMID: 49468
  14. A plaque assay on agar for detection of gram-negative bacilli sensitive to complement.
    J Immunol. 1972 Nov;109(5):1156-8 PMID: 4562427
  15. Experimental bacterial endocarditis. 3. Production and progress of the disease in rabbits.
    Br J Exp Pathol. 1973 Apr;54(2):142-51 PMID: 4700697
  16. Changing etiology of bacterial endocarditis in the antibacterial era. Experiences at Boston City Hospital 1933-1965.
    Ann Intern Med. 1970 Mar;72(3):341-8 PMID: 4984425
  17. Sensitivity of serologically classified strains of escherichia coli of human origin to the serum bactericidal system.
    Am J Med Sci. 1970 Feb;259(2):114-9 PMID: 4905231
  18. Escherichia coli endocarditis. A review of the literature and a case study.
    Arch Intern Med. 1967 Oct;120(4):472-7 PMID: 4862265
  19. The serum bactericidal reaction. 3. Antibody and complement requirements for killing a rough Escherichia coli.
    J Immunol. 1969 Jun;102(6):1379-87 PMID: 4891549
  20. Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity.
    J Clin Invest. 1976 Feb;57(2):283-90 PMID: 815273
  21. Absence of the sixth component of complement in a patient with repeated episodes of meningococcal meningitis.
    J Pediatr. 1976 Jul;89(1):42-7 PMID: 819642
  22. Experimental endocarditis due to Pseudomonas aeruginosa. I. Description of a model.
    J Infect Dis. 1976 Jul;134(1):1-7 PMID: 820812
  23. Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.
    J Clin Invest. 1976 Jun;57(6):1626-34 PMID: 932197
  24. Experimental bacterial endocarditis. IV. Structure and evolution of very early lesions.
    J Pathol. 1975 Feb;115(2):81-9 PMID: 1151519
  25. Hereditary deficiency of the sixth component of complement in man. I. Immunochemical, biologic, and family studies.
    J Clin Invest. 1974 Feb;53(2):544-53 PMID: 11344568
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1977-04-00
Pages
213-7
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC421510
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]